20240024258. TREATMENT REGIMEN FOR ONCHYOMYCOSIS USING ALLYLAMINE ANTIFUNGAL COMPOSITIONS simplified abstract (MOBERG PHARMA AB)

From WikiPatents
Jump to navigation Jump to search

TREATMENT REGIMEN FOR ONCHYOMYCOSIS USING ALLYLAMINE ANTIFUNGAL COMPOSITIONS

Organization Name

MOBERG PHARMA AB

Inventor(s)

[[:Category:Torbjörn W�rnheim of Spånga (SE)|Torbjörn W�rnheim of Spånga (SE)]][[Category:Torbjörn W�rnheim of Spånga (SE)]]

Amir Tavakkol of Mountain Lakes NJ (US)

TREATMENT REGIMEN FOR ONCHYOMYCOSIS USING ALLYLAMINE ANTIFUNGAL COMPOSITIONS - A simplified explanation of the abstract

This abstract first appeared for US patent application 20240024258 titled 'TREATMENT REGIMEN FOR ONCHYOMYCOSIS USING ALLYLAMINE ANTIFUNGAL COMPOSITIONS

Simplified Explanation

The patent application describes a method of treating onychomycosis (fungal infection of the nail) using a topical pharmaceutical composition. The composition contains an antifungal allylamine compound and a non-aqueous solvent system. The method involves two phases: a loading phase where the composition is applied at least three times a week, followed by a maintenance phase where it is applied no more than two times per week. Additionally, the application describes pharmaceutical compositions suitable for topical application to the nail, which include an antifungal allylamine compound, an organic acid component, and a diol component.

  • The patent application describes a method of treating onychomycosis using a topical pharmaceutical composition.
  • The composition includes an antifungal allylamine compound and a non-aqueous solvent system.
  • The treatment method involves a loading phase with frequent application of the composition, followed by a maintenance phase with less frequent application.
  • The patent application also describes specific pharmaceutical compositions for topical application to the nail, which include an antifungal allylamine compound, an organic acid component, and a diol component.

Potential Applications:

  • Treatment of onychomycosis (fungal infection of the nail)
  • Pharmaceutical industry for the development of antifungal treatments

Problems Solved:

  • Provides a method for effectively treating onychomycosis using a topical application, which may be more convenient and less invasive than other treatment methods.
  • Addresses the need for a loading phase followed by a maintenance phase to optimize the treatment efficacy.

Benefits:

  • Offers a non-invasive treatment option for onychomycosis.
  • Provides flexibility in the treatment schedule with the loading and maintenance phases.
  • The specific pharmaceutical compositions described may enhance the antifungal activity and effectiveness of the treatment.


Original Abstract Submitted

there is provided a method of treating onychomycosis of the nail, comprising topical application of a pharmaceutical composition comprising an antifungal allylamine compound and a non-aqueous solvent system, which method comprises a loading phase, during which the pharmaceutical composition is administered at least three times a week, followed by a maintenance phase, during which the pharmaceutical composition is administered no more than two times per week. there are further provided pharmaceutical compositions suitable for topical application to the nail comprising an antifungal allylamine compound, an organic acid component and a diol component, as defined herein, and their use in methods of treating onychomycosis.

Retrieved from "http://wikipatents.org/index.php?title=20240024258._TREATMENT_REGIMEN_FOR_ONCHYOMYCOSIS_USING_ALLYLAMINE_ANTIFUNGAL_COMPOSITIONS_simplified_abstract_(MOBERG_PHARMA_AB)&oldid=29445"